{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:50:03Z","timestamp":1790859003616,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000109","name":"Prostate Cancer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010875","name":"Amgen Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014554","name":"Janssen Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.eururo.2014.06.005","type":"journal-article","created":{"date-parts":[[2014,6,18]],"date-time":"2014-06-18T19:29:11Z","timestamp":1403119751000},"page":"841-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Obesity Is Associated with Risk of Progression for Low-risk Prostate Cancers Managed Expectantly"],"prefix":"10.1016","volume":"66","author":[{"given":"Bimal","family":"Bhindi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbir M.H.","family":"Alibhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ants","family":"Toi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus H.","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hersey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.S.","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre R.","family":"Zlotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Trachtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Fleshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.06.005_bib0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","article-title":"Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer","volume":"28","author":"Klotz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0010","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","article-title":"Obesity and prostate cancer: weighing the evidence","volume":"63","author":"Allott","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0015","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/ATVBAHA.111.241927","article-title":"Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer","volume":"32","author":"Hursting","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0020","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/annonc\/mdr603","article-title":"Body mass index and incidence of localized and advanced prostate cancer\u2014a dose-response meta-analysis of prospective studies","volume":"23","author":"Discacciati","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1158\/1940-6207.CAPR-10-0229","article-title":"Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis","volume":"4","author":"Cao","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.eururo.2014.06.005_bib0030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2014.06.005_bib0035","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/cncr.22443","article-title":"Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality","volume":"109","author":"Wright","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.06.005_bib0040","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.298.19.2275","article-title":"Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer","volume":"298","author":"Banez","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2014.06.005_bib0045","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/pcan.2011.31","article-title":"Predictive value of digital rectal examination for prostate cancer detection is modified by obesity","volume":"14","author":"Chu","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2014.06.005_bib0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0022-5347(05)00162-X","article-title":"Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection","volume":"175","author":"Freedland","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.urology.2013.07.039","article-title":"Obesity is associated with larger prostate volume but not with worse urinary symptoms: analysis of a large multiethnic cohort","volume":"83","author":"Bhindi","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.06.005_bib0060","doi-asserted-by":"crossref","unstructured":"Bhindi B, Locke J, Alibhai SM, et al. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort. Eur Urol. In press. http:\/\/dx.doi.org\/10.1016\/j.eururo.2014.01.040","DOI":"10.1016\/j.eururo.2014.01.040"},{"key":"10.1016\/j.eururo.2014.06.005_bib0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.urology.2006.10.036","article-title":"Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications","volume":"69","author":"Freedland","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.06.005_bib0075","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.eururo.2011.07.041","article-title":"The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance","volume":"61","author":"Ploussard","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0080","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1002\/cncr.28303","article-title":"Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer","volume":"119","author":"Truong","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.06.005_bib0085","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.urology.2009.12.073","article-title":"Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database","volume":"76","author":"Kane","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.06.005_bib0090","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1464-410X.2011.10543.x","article-title":"Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours","volume":"109","author":"Corcoran","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2014.06.005_bib0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1532-5415.2008.02091.x","article-title":"Cause of death in older men after the diagnosis of prostate cancer","volume":"57","author":"Ketchandji","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.eururo.2014.06.005_bib0100","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1200\/JCO.2009.27.0793","article-title":"Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival","volume":"28","author":"Nguyen","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0105","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/djt332","article-title":"Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG","volume":"105","author":"Pettersson","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2014.06.005_bib0110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1113135","article-title":"Prostate-cancer mortality at 11 years of follow-up","volume":"366","author":"Schroder","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2014.06.005_bib0115","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jama.2009.1348","article-title":"Outcomes of localized prostate cancer following conservative management","volume":"302","author":"Lu-Yao","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2014.06.005_bib0120","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archinternmed.2010.221","article-title":"Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng\/ml","volume":"170","author":"Shao","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eururo.2014.06.005_bib0125","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(11)61619-X","article-title":"Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial","volume":"379","author":"Fleshner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2014.06.005_bib0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.eururo.2010.12.018","article-title":"Impact of 5\u03b1-reductase inhibitors on men followed by active surveillance for prostate cancer","volume":"59","author":"Finelli","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0135","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2014.06.005_bib0140","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2014.06.005_bib0145","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2012.46.7043","article-title":"Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes","volume":"31","author":"Margel","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.06.005_bib0150","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.eururo.2012.11.012","article-title":"The relationship between nutrition and prostate cancer: is more always better?","volume":"63","author":"Masko","year":"2013","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814005260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814005260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:05:04Z","timestamp":1759583104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814005260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0302283814005260"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.06.005","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity Is Associated with Risk of Progression for Low-risk Prostate Cancers Managed Expectantly","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}